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ABSTRACT
Glutamatergic dysfunction has been suggested as a possible substrate of the pathophysiology of many neurodegenerative 
diseases, specifically since glutamatergic transmission is severely altered by the early degeneration of cortico-cortical 
connections and hippocampal projections in Alzheimer’s disease, schizophrenia and Huntington’s disease in humans. 
Of the multiple genes, vesicular glutamate transporters, glutamate receptors and excitatory amino acid transporters 
have a significant role in glutamatergic transmissions. The regional differences of glutamatergic neurons and glutamate 
receptor neurons suggest many glutamatergic projections in the avian brain. Glutamatergic target areas are expected to 
show high activity of glutamate transporters that remove the released glutamate from the synaptic clefts. The distribution 
of the glutamate-related genes indicates that many glutamatergic transmissions exist in the avian brain. This review 
provide insights of glutamatergic circuits in birds particularly in the pallial organization of glutamatergic neurons and 
connection with the striatum and hippocampal-septal pathway and comparison with those of mammalian brain which 
are responsible for Alzheimer’s disease, schizophrenia and Huntington’s disease in humans.
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ABSTRAK
Disfungsi Glutamatergik telah dicadangkan sebagai substrat patofisiologi yang mungkin untuk penyakit neurodegeneratif, 
khususnya kerana penghantaran glutamatergik banyak diubah oleh degenerasi awal sambungan kortikal kortiko dan 
unjuran hipokampal dalam penyakit Alzheimer, skizofrenia dan penyakit Huntington pada manusia. Daripada pelbagai 
gen yang ada, pembawa glutamat vesikular, reseptor glutamat dan pembawa asid amino berangsang mempunyai 
peranan penting dalam transmisi glutamatergik. Perbezaan serantau neuron glutamatergik dan neuron reseptor glutamat 
mencadangkan terdapat banyak unjuran glutamatergik wujud di dalam otak burung. Kawasan sasaran Glutamatergik 
dijangka menunjukkan aktiviti pengangkutan glutamat yang tinggi bagi membuang glutamat yang dikeluarkan dari celahan 
sinaptik. Taburan gen yang berkaitan glutamat menunjukkan bahawa banyak penghantaran glutamatergik wujud di dalam 
otak burung. Ulasan ini menyediakan gambaran tentang litar glutamatergik dalam burung terutamanya dalam organisasi 
palial neuron glutamatergik dan perkaitan dengan striatum dan laluan septal hipokampal serta perbandingan dengan 
otak mamalia yang bertanggungjawab bagi penyakit Alzheimer, skizofrenia dan penyakit Huntington pada manusia. 
  
Kata kunci: Neuron; pembawa glutamat vesikular; reseptor glutamat; sistem saraf pusat; ungkapan mRNA 
INTRODUCTION
Glutamate is the major excitatory neurotransmitter in the 
central nervous system (CNS) (Headley & Grillner 1990) 
but excessive glutamate in the synaptic cleft produces 
excitotoxicity in the CNS (Brustovetsky et al. 2004; 
Obrenovitch & Urenjak 1997). Interruption of glutamatergic 
circuit is one of the important grounds for glutamate deposit 
in the synaptic cleft causing excitotoxicity. Excitotoxicity 
involved in neurodegenerative diseases in the CNS of 
human such as Alzheimer’s disease, schizophrenia, 
Parkinson’s disease, Huntington’s disease, multiple 
sclerosis, amyotrophic lateral sclerosis (ALS) as well as 
spinal cord injury and stroke (Kim et al. 2002). 
 Vesicular glutamate transporters (VGLUTs) transport 
and store glutamate into synaptic vesicles at the 
presynaptic terminals, then the glutamate are released into 
the synaptic cleft by exocytosis and binds to glutamate 
receptors (GluRs) on postsynaptic membranes. The 
excitatory amino acid transporters (EAATs) or high-affinity 
glutamate transporters play essential roles in removing 
the released glutamate from the synaptic cleft (Kanai & 
Hediger 2004).  Thus VGLUTs, GluRs and EAATs boast 
a significant role in glutamatergic transmission (Figure 
1) to uncover amenable targets that may contribute to 
our understanding of glutamate excitotoxicity. Three 
subtypes of VGLUTs have been identified in mammals and 
are referred to as VGLUT1, VGLUT2, and VGLUT3 (Aihara 
et al. 2000; Gras et al. 2002; Ni et al. 1994). VGLUT1 
and VGLUT2 mRNAs are expressed in the glutamatergic 
neurons, whereas the VGLUT3 mRNA is found in other types 
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of neurons and in the astrocytes (Bai et al. 2001; Gras et 
al. 2002; Herzog et al. 2004; Takamori 2006). In general, 
VGLUT1 and VGLUT2 show a complementary expression 
pattern of the glutamatergic neurons in the mammalian 
brain; VGLUT1 mRNA is expressed mainly in the cerebral 
cortex, hippocampus and cerebellar cortex, whereas 
the greatest expression of VGLUT2 mRNA is seen in the 
thalamus, hypothalamus, lower brainstem and cerebellar 
nuclei (Barroso-Chinea et al. 2007; Fremeau et al. 2001; 
Hisano et al. 2000). Because of VGLUT1 and VGLUT2 are 
restricted to known glutamatergic neurons, their presence 
have become a reliable molecular phenotypic marker 
to identify the glutamatergic neurons (Takamori et al. 
2000). Cellular detection of VGLUT2 mRNA is so far the 
only available and reliable method to label cell bodies 
of glutamatergic neurons, because VGLUT1 mRNA is not 
known yet in birds. The postsynaptic actions of glutamate 
are mediated by at least three major pharmacologically 
distinct classes of ionotropic receptors at which glutamate 
modulates the release of intracellular Ca2+ as well as 
metabotropic receptors. The ionotropic receptors contain 
glutamate-gated cation channels and are named according 
to their selective agonists as N-methyl-D-aspartate 
(NMDA)-type, α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid (AMPA)-type and kainite-type receptors 
(Collingridge & Lester 1989). AMPA-type glutamate 
receptors, which mediate fast excitatory postsynaptic 
potentials, are assembled as GluR1, GluR2, GluR3 and 
GluR4 (Keinänen et al. 1990). GluR1–4 subtypes mRNA 
and proteins are expressed differentially and widely in 
the neurons of the birds and mammalian CNS (Conti et al. 
1994; Keinänen et al. 1990; Islam & Atoji 2008; Ottiger 
et al. 1995; Sato et al. 1993; Theiss et al. 1998; Toledo et 
al. 2002; Wada et al. 2004). Five excitatory amino acid 
transporters have been cloned in mammals: L-glutamate 
transporter 1 (GLT1) or excitatory amino acid transporter 
2 (EAAT2) (Pines et al. 1992), excitatory amino acid 
carrier 1 (EAAC1) or EAAT3 (Kanai & Hediger 1992); 
L-glutamate / L-aspertate transporter (GLAST) or EAAT1 
(Storck et al. 1992), EAAT4 (Fairman et al. 1995) and 
EAAT5 (Arriza et al. 1997). In contrast, GLT1 is the only 
identified glutamate transporter in birds (Atoji & Islam 
2009). GLT1 preferentially expresses in the telencephalon, 
including the olfactory bulb, neocortex, hippocampus and 
striatum is also present in the cerebellum at lower levels 
(Atoji & Islam 2009; Berger & Hediger 1998; Danbolt et 
al. 1992; Lehre et al. 1995; Schmitt et al. 2002). Both the 
neurons and glial cells exhibit high capacity for glutamate 
uptake (Genelassvili & Schousboe 1998). The cortico-
striatal pathway and hippocampal-septal pathway are 
shown glutamatergic transmission in mammals (Gerfen 
2004; Witter & Amaral 2004). In contrast, the regional 
differences of glutamatergic neurons and AMPA-type 
receptor neurons suggest many glutamatergic projections 
in the avian brain. Glutamatergic target areas are expected 
to show high activity of glutamate transporters that 
remove the released glutamate from the synaptic clefts. 
Thus, the distribution of the glutamate-related genes 
indicates that many glutamatergic transmissions also 
exist in the avian brain. This review provide insights 
of glutamatergic transmission in birds and comparison 
with those of mammalian brain, particularly in the pallial 
organization of glutamatergic neurons and connection 
with the striatum and hippocampal-septal pathway 
which are responsible for Huntington’s disease (HD), 
Alzheimer’s disease and schizophrenia in humans.
FIGURE 1. Schematic diagram of glutamatergic transmission in mammals is regulated 
by the vesicular glutamate transporter (VGLUTs), glutamate receptors (GluRs), and 
excitatory amino acid transporters (EAATs)
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HUNTINGTON’S DISEASE AND 
GLUTAMATERGIC TRANSMISSION
The main hypothesis underlying striatal neurodegeneration 
in HD has been excitotoxicity (Difiglia 1990). This 
hypothesis emanated from many studies demonstrating 
parallels in the effects of excitotoxicity or chemical lesions 
of the striatum with those observed in HD in patients. 
In general, excitotoxicity can result from a number of 
changes, either together or in isolation. These include an 
increase in release of excitatory neurotransmitters like 
glutamate and an increase in responsiveness of glutamate 
receptors (GluRs) either due to an increase in receptor 
density or number or a change in receptor composition 
or their signaling properties. Neuronal glutamatergic 
transmission in both the striatum and cortex are important 
in the development of the HD phenotype. The corticostriatal 
pathway is the primary provider of the excitatory 
glutamatergic inputs into the striatum. The effects of 
these inputs are regulated by AMPA GluRs receptors 
on cortico-striatum that function as the gatekeepers of 
glutamate receive, as well as by the intrinsic membrane 
properties of medium-sized spiny neurons. When the 
neurons of this pathway become dysfunctional, excitation 
of striatal neurons will become abnormal. Furthermore, it 
is becoming increasingly clear that major morphological 
alterations in the striatum are probably primed initially 
by alterations in the intrinsic functional properties of 
medium-sized spiny neurons (Cepeda et al. 2007). It is 
thus possible that areas related to these early alterations, 
such as the limbic system, the cerebral cortex or even the 
hypothalamus is the initial triggers of changes in motor 
functions ultimately mediated via the striatum. In fact, it 
has been speculated that cortical changes are fundamental 
to the onset and progression of the HD in humans and in 
mouse models (Cepeda et al. 2007) that can be study by 
the avian models. 
 In corticostriatal pathway, the cerebral cortex provides 
a major input to the striatum. The corticostriatal afferents 
arise from cortical pyramidal neurons, located primarily 
in layer V, with layers III and VI. The topographic 
organization of corticostriatal inputs is well established 
with the orderly mapping of inputs of regions of the 
cortex into the topographically related regions of the 
striatum. Frontal areas provide inputs to the rostral regions 
of the striatum, sensorimotor cortex provides inputs to 
the dorso-lateral region and parietal cortex provides 
inputs to more caudal regions (Gerfen 2004). VGLUT1 
mRNA is strongly expressed in layers V and VI, VGLUT2 
mRNA is expressed in layers IV and VI of some lobes of 
the cerebral cortex (Fremeau et al. 2001; Herzog et al. 
2004). The immunoreactivity of VGLUT1 and VGLUT2 is 
intense in the neocortex (Kaneko et al. 2002). In birds, 
chicken VGLUT2 and VGLUT3 genes have been identified, 
but the VGLUT1 gene has not been found. Islam and Atoji 
(2008) reported the sequence of pigeon VGLUT2 cDNA 
(accession number: FJ428226), whose amino acid shows 
99% and 93% identity to the chicken and human VGLUT2, 
respectively. The previous in situ hybridization study and 
immunohistochemistry demonstrated that VGLUT2 mRNA 
and protein was distributed in neuronal cell bodies and 
neuropil, respectively, in the pallium of the telencephalon, 
many nuclei in the ascending auditory and visual systems 
and in granule cells of the cerebellar cortex (Atoji 2011; 
Islam & Atoji 2008). On the other hand, GluR1-4 subtypes 
mRNA or protein is labeled in neurons of the striatum 
(Keinänen et al. 1990; Martin et al. 1993; Sato et al. 1993). 
GLT1 mRNA is expressed in the caudate putamen and globus 
pallidus in rat brain (Berger & Hediger 1998; Torp 1997). 
Thus, the glutamatergic neurons inhabit in cortical layers 
that provide major excitatory input to the striatum. The 
hyperpallium (apical, interstitial nucleus of the apical, 
intercalated and densocellular parts of the hyperpallium) 
of birds and mammalian neocortex appear to derive from 
the same pallial embryonic subdivision. The adult animals 
show the typical molecular and cellular features in these 
structures (Medina 2007). In the avian brain, VGLUT2, 
GluR1-4 and GLT1 mRNAs expression was also found 
differentially in the pallium of birds. The principal pallial 
neurons have excitatory projections to the striatum in 
birds (Veenman et al. 1995) and in mammals (Broman et 
al. 2004). The striatum showed the positive expression for 
AMPA glutamate receptors in birds and mammals (Cornil 
et al. 2000; Islam & Atoji, 2008; Laverghetta et al. 2006; 
Ottiger et al. 1995; Sato et al. 1993; Wada et al. 2004). GLT1 
mRNA showed positive expression in the glutamatergic 
terminal fields, i.e., in the striatum of birds (Atoji & Islam 
2009). Thus, glutamatergic circuits exist in the pallial-
striatal pathway of the avian brain like as mammalian brain. 
SCHIZOPHRENIA AND GLUTAMATERGIC TRANSMISSION
The AMPA receptor and VGLUTs are abnormally expressed 
in schizophrenic brain. AMPA receptor expression is 
decreased in the medial temporal lobe, hippocampus 
particularly in the CA3 and CA4 subfields in schizophrenic 
brain, but there were no differences in the expression of 
any of the AMPA-associated subunit mRNAs in prefrontal 
or occipital cortex in schizophrenia (Kerwin et al. 1990; 
Meador-Woodruff & Healy 2000). While Noga et al. (1997) 
reported increased AMPA binding in caudate, putamen 
and accumbens in schizophrenic brain. VGLUT2 mRNA 
expression was increased in the thalamus in schizophrenia 
patents, whereas VGLUT1 mRNA expression was decreased 
(Eastwood et al. 2005; Smith et al. 2001).
ALZHEIMER’S DISEASE AND 
GLUTAMATERGIC TRANSMISSION
Alzheimer’s disease, the leading cause of senile dementia, 
is characterized by the dysfunction and degeneration 
of select populations of vulnerable neurons in the 
hippocampus and other cortical brain regions. In previous 
studies, it was suggested that such selective neuronal 
vulnerability may arise through the differential expression 
of glutamate receptors, the activation of which would lead 
to signal transduction alterations (McShea et al. 1999; 
Perry et al. 1999; Zhu et al. 2001). Although it is still 
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not clear which receptor or receptor classes are involved 
in these signal transduction alterations in Alzheimer’s 
disease, the glutamate receptor (GluR) family is likely to 
play a pivotal role. Indeed, previous reports support this 
notion and glutamatergic transmission is severely altered 
by early degeneration of corticocortical connections and 
hippocampal projections in Alzheimer’s disease (Francis et 
al. 1993). These studies support the hypothesis of abnormal 
glutamatergic neurotransmission in Alzheimer’s disease 
and schizophrenia that involves the ionotropic GluRs in 
particular. These findings suggest that novel strategies that 
permit the modulation of these receptors may prove to be 
of therapeutic utility in these illnesses.
 In mammals, dentate gyrus has mossy fiber projection 
to the CA3 field of the hippocampus and the septal nuclei 
have projection to the dentate gyrus (Witter & Amaral 
2004). Granule cells in the dentate gyrus and pyramidal 
cells in the Ammon’s horn contain glutamatergic neurons 
(Fremeau et al. 2001; Kaneko et al. 2002). GluR1–3 
mRNA is strongly expressed in the pyramidal cells of the 
Ammon’s horn, including CA3, which receives the mossy 
fibers from granule cells of the dentate gyrus (Keinänen 
et al. 1990; Sato et al. 1993). Ammon’s horn, which 
projects one of the main efferents to the lateral septal 
nucleus, is highly enriched in GluR1–3 immunoreactivity 
as well as in VGLUT1 mRNA (Fremeau et al. 2001; Martin 
et al. 1993; Rogers et al. 1991). Moreover, the lateral 
septal nucleus shows intense immunoreactivity for 
GluR1–3, especially on somata and dendrites (Martin et 
al. 1993; Rogers et al. 1991). These findings indicate that 
glutamatergic granule cells in the dentate gyrus give rise 
to intrahippocampal projections to pyramidal cells in CA3 
and in turn, glutamatergic pyramidal cells in the Ammon’s 
horn project extrahippocampal efferents to the lateral septal 
nucleus. The avian hippocampal formation consists of 
seven subdivisions; among of them, the V-shaped layer, 
the triangular and dorsomedial regions are comparable 
with the dentate gyrus and Ammon’s horn, respectively, 
based on fiber connections with the septum (Atoji & Wild 
2004; Atoji et al. 2006). Neurons in the V-shaped layer 
form intrinsic circuits to the triangular and dorsomedial 
regions and neurons in the triangular and dorsomedial 
regions project to the lateral septal nucleus. VGLUT2 
mRNA expresses in neurons of the V-shaped layer and 
of the triangular and dorsomedial regions, and GluR1-4 
mRNAs expression and protein localization are found in 
neurons of the triangular and dorsomedial regions and in 
the lateral septal nucleus (Islam & Atoji 2008; Ottiger et 
al. 1995; Wada et al. 2004). GLT1 mRNA is identified in 
the glial cells throughout the hippocampal formation and 
the septum (Atoji & Islam 2009). Therefore, it seems to 
believe that glutamatergic circuits dwell in hippocampal-
septal connection in birds.
 In conclusion, this review emphasizes the 
morphological distribution of glutamate-related genes – 
VGLUTs, GluRs and GLT1 contribute to our understanding 
of glutamatergic transmission as exhibited in corticostriatal 
pathway, hippocampal-septal pathway and other relevant 
areas of the avian brain. Furthermore, glutamatergic circuits 
will provide the morphological basis for physiological 
and pharmacological experiments using birds as the 
potential animal models to elucidate further the underlying 
mechanisms that underlie glutamatergic transmission 
both in health as well as in excitotoxic neurodegenerative 
diseases. 
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